RAMMF
Price:
$0.055
Market Cap:
$1.19M
RAMM Pharma Corp. engages in the research and development, production, and sale of cannabinoid pharmaceutical formulations, pharmaceuticals, cosmetics, nutraceutical products, and resale of medical supplies products in Canada and internationally. It offers Epifractán, a cannabinoid pharmaceutical drug; XALEX 10, a prescription pharmaceutical formulation for the treatment of refractory epilepsy; and NettaLife, a cannabis-based product for pets. The company was formerly known as MTC Growth Fund-I Inc. and changed its name to RAMM Pharma Corp. in October 2019. RAMM Pharma Corp. was incorporated in 1987 and is based in Toronto, Canada.[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2020-12-14
Stock Exchange
PNK
Ticker
RAMMF
According to RAMM Pharma Corp.’s latest financial reports and current stock price. The company's current ROE is -32.53%. This represents a change of 309.09% compared to the average of -7.95% of the last 4 quarters.
The mean historical ROE of RAMM Pharma Corp. over the last ten years is 27.56%. The current -32.53% ROE has changed -218.02% with respect to the historical average. Over the past ten years (40 quarters), RAMMF's ROE was at its highest in in the January 2019 quarter at 133.79%. The ROE was at its lowest in in the October 2022 quarter at -46.24%.
Average
27.56%
Median
-19.31%
Minimum
-58.90%
Maximum
301.71%
Discovering the peaks and valleys of RAMM Pharma Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 367.36%
Maximum Annual ROE = 301.71%
Minimum Annual Increase = -105.93%
Minimum Annual ROE = -58.90%
Year | ROE | Change |
---|---|---|
2023 | -26.20% | -55.51% |
2022 | -58.90% | 367.36% |
2021 | -12.60% | -39.22% |
2020 | -20.74% | 15.93% |
2019 | -17.89% | -105.93% |
The current ROE of RAMM Pharma Corp. (RAMMF) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-32.57%
5-year avg
-27.27%
10-year avg
27.56%
RAMM Pharma Corp.’s ROE is less than City View Green Holdings Inc. (51.86%), greater than Speakeasy Cannabis Club Ltd. (-16.76%), less than Pure Harvest Corporate Group, Inc. (14.51%), greater than RavenQuest BioMed Inc. (-203.42%), greater than Craftport Cannabis Corp. (-194.22%),
Company | ROE | Market cap |
---|---|---|
51.86% | $1.96M | |
-16.76% | $1.31K | |
14.51% | $430.44K | |
-203.42% | $482.11K | |
-194.22% | $6.36B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like RAMM Pharma Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like RAMM Pharma Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is RAMM Pharma Corp.'s ROE?
How is the ROE calculated for RAMM Pharma Corp. (RAMMF)?
What is the highest ROE for RAMM Pharma Corp. (RAMMF)?
What is the 3-year average ROE for RAMM Pharma Corp. (RAMMF)?
What is the 5-year average ROE for RAMM Pharma Corp. (RAMMF)?
How does the current ROE for RAMM Pharma Corp. (RAMMF) compare to its historical average?